Skip to main content
. Author manuscript; available in PMC: 2020 Feb 24.
Published in final edited form as: Lancet Haematol. 2019 Jun 14;6(8):e419–e428. doi: 10.1016/S2352-3026(19)30104-8

Table 4:

Non-haematologic grade ≥3 serious adverse events (N=85)

Grade n (%)
Atrial fibrillation 3 3 (4)
Pneumocystis jiroveci pneumonia 3 1 (1)
Appendicitis 3 1 (1)
Cholecystitis 4 1 (1)
Anaplasmosis infection 3 1 (1)
Pneumatosis intestinalis 3 1 (1)
Lipase elevation 4 1 (1)
Diarrhoea 3 1 (1)
Nausea/vomiting 3 1 (1)
Cellulitis 3 1 (1)
Appendiceal mucocele 3 1 (1)
Respiratory syncytial virus infection 3 1 (1)